Showing results (141-150 of 162) with videos related to
Sort By:
Pageof 17
Journal of Experimental & Clinical Cancer Research : CR|May 16, 2019
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancerAikaterini Emmanouilidi, Chanse A Fyffe, Riccardo Ferro, et al.Oncogene|February 3, 2004
Inositol pentakisphosphate promotes apoptosis through the PI 3-K/Akt pathwayEnza Piccolo, Sara Vignati, Tania Maffucci, et al.Journal of Experimental & Clinical Cancer Research : CR|December 8, 2020
Rhenium N-heterocyclic carbene complexes block growth of aggressive cancers by inhibiting FGFR- and SRC-mediated signallingAlice Domenichini, Ilaria Casari, Peter V Simpson, et al.Cancers|March 29, 2023
TWEAK/Fn14 Signalling Regulates the Tissue Microenvironment in Chronic PancreatitisN Dianah B Abu Bakar, Rodrigo Carlessi, Jully Gogoi-Tiwari, et al.Journal of Experimental & Clinical Cancer Research : CR|November 23, 2019
Downregulation of class II phosphoinositide 3-kinase PI3K-C2β delays cell division and potentiates the effect of docetaxel on cancer cell growthOuma Cisse, Muzthahid Quraishi, Federico Gulluni, et al.Cellular and Molecular Life Sciences : CMLS|December 1, 2018
Identification of CD36 as a new interaction partner of membrane NEU1: potential implication in the pro-atherogenic effects of the elastin receptor complexCharlotte Kawecki, Olivier Bocquet, Christian E H Schmelzer, et al.Cancer Research|February 22, 2018
A Novel Mechanism for Activation of GLI1 by Nuclear SMO That Escapes Anti-SMO InhibitorsMuhammad M Rahman, Allon Hazan, Joanne L Selway, et al.European Journal of Medicinal Chemistry|September 5, 2025
Synthesis and biological evaluation of N-O heterobicyclic ring systems derived from 1,2-dihydropyridines as novel TRPA1 activators: implication in GLP-1 release and neuroprotectionLucrezia Margherita Comparini, Valentina Citi, Gabriella Ortore, et al.Cancer Research|September 17, 2005
Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effectsTania Maffucci, Enza Piccolo, Albana Cumashi, et al.Oncotarget|March 3, 2016
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progressionAnissa Chikh, Riccardo Ferro, Jonathan J Abbott, et al.Pageof 17